Genome Editing and Heart Failure

Area of Science:

• Cardiology
• Genetics
• Biotechnology

Background:

• Heart failure is a significant cause of global morbidity and mortality.
• Risk factors for heart failure with reduced ejection fraction overlap with chronic coronary syndrome.
• Genetic predisposition to cardiomyopathies contributes to heart failure development.

Purpose of the Study:

• To explain the pathophysiology and genetics of heart failure.
• To discuss the clinical applications of genome editing for heart failure treatment.

Main Methods:

• Review of pathophysiological and genetic aspects of heart failure.
• Exploration of genome editing technologies for genetic defect correction.
• Discussion of genome editing applications in clinical settings.

Main Results:

• Genome editing technologies can correct specific mutations causing cardiomyopathies.
• These technologies hold potential for modulating and improving cardiac function.
• Clinical applications of genome editing in heart failure are being explored.

Conclusions:

• Genome editing presents a promising therapeutic avenue for heart failure.
• Targeting genetic defects offers a novel approach to managing heart failure.
• Further research is needed to fully realize the clinical potential of genome editing in cardiology.